title: Burkitt's lymphoma shortly after an acute HIV infection, treated with highly active retroviral treatment.
authors.forename: R
authors.initials: R
authors.lastname: Colebunders
authors.forename: S
authors.initials: S
authors.lastname: Dohmen
authors.forename: A
authors.initials: A
authors.lastname: Van de Velde
authors.forename: J
authors.initials: J
authors.lastname: Pelgrom
authors.forename: P
authors.initials: P
authors.lastname: Hermans
mesh_terms: D000208:Acute Disease; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002051:Burkitt Lymphoma / Q000175:diagnosis* / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy; D018451:Homosexuality, Male; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D019380:Anti-HIV Agents; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone